942190-60-5 Usage
Description
Tert-Butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate is a chemical compound characterized by a pyrrolidine ring with a tert-butyl group and a cyano group attached to it. It also features a trimethylsilyloxy group, which serves as a protecting group in organic synthesis to prevent unwanted reactions. The carboxylate group at the end of the molecule signifies that it is an ester, a compound derived from an acid with at least one hydroxyl group replaced by an alkoxyl group. This unique structure and reactivity may make it suitable for applications in organic synthesis, pharmaceuticals, and materials science.
Uses
Used in Organic Synthesis:
Tert-Butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate is used as a protecting group in organic synthesis for the pyrrolidine ring. Its trimethylsilyloxy group helps prevent unwanted reactions, allowing chemists to selectively modify other parts of the molecule.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, tert-Butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate may be used as a building block or intermediate in the synthesis of various drug molecules. Its unique structure and reactivity can contribute to the development of new therapeutic agents.
Used in Materials Science:
Tert-Butyl 3-cyano-3-((trimethylsilyl)oxy)pyrrolidine-1-carboxylate may also find applications in materials science, where its unique structure and reactivity could be utilized to create new materials with specific properties for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 942190-60-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,2,1,9 and 0 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 942190-60:
(8*9)+(7*4)+(6*2)+(5*1)+(4*9)+(3*0)+(2*6)+(1*0)=165
165 % 10 = 5
So 942190-60-5 is a valid CAS Registry Number.
942190-60-5Relevant articles and documents
COMPOUNDS USEFUL AS IMMUNOMODULATORS
-
Paragraph 0452; 0453; 0454; 0455, (2017/05/07)
The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS
-
Page/Page column 51; 59, (2010/04/28)
Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Ql, Q2, Rl, R2 and R3 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS
-
Page/Page column 44; 146, (2009/06/27)
Compounds of structure (I): having antibacterial activity are disclosed, including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Q3, R8 and R9 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
